resources

The stock has been placed in Additional Surveillance Measure (ASM) list LTASM - I.

Choksi Laboratories Ltd.

BSE: 526546

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Healthcare Service Provider

137.00+5.9 (+4.50%)

21 Aug, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Choksi Laboratories Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	—
Quarterly Results	—	—	—	—	—	—	Mar Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun
Conference Calls	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Presentations	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Corporate Announcements and Regulatory Filings

Choksi Laboratories Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

General21 Aug 2026
Intimation Under Regulation 30 For Inspection Of USFDA
Intimation under Regulation 30 of SEBI (LODR) 2015 for inspection of USFDA
Newspaper Publication21 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of newspaper clipping of information regarding 33rd Annual General Meeting of the company
Newspaper Publication14 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of unaudited financial result for the quarter ended 30th June, 2026
Change in Management13 Aug 2026
Announcement under Regulation 30 (LODR)-Change in Management
Reappointment of Internal Auditor for the F.Y. 2026-27
Change in Management13 Aug 2026
Announcement under Regulation 30 (LODR)-Change in Management
Reappointment of Ms. Himika Choksi as Whole Time Director for further period of five year w.e.f 01.04.2027 subject to approval from shareholders in the ensuing AGM.
Outcome of Board Meeting13 Aug 2026
Board Meeting Outcome for Board Meeting Held On 13.08.2026
1. Considered and approved the Unaudited Financial Results for the Quarter ended on 30th June, 2026 along with the Limited review report; 2. Decided the date for closure of Register of ....
Newspaper Publication4 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of information regarding change of RTA
Allotment of Warrants3 Aug 2026
Announcement under Regulation 30 (LODR)-Change in RTA
Intimation for change of RTA in pursuant to Regulation 30 of SEBI (LODR) 2015
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Closure of Trading Window26 Jun 2026
Closure of Trading Window
Intimation for Closure of trading window w.e.f. 01st July, 2026
Newspaper Publication26 May 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of newspaper publication of financial result for the period ended 31.03.2026
Reg.24(A)-Annual Secretarial Compliance25 May 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
Submission of Annual Secretarial Compliance report under Regulation 24A issued by M/s Surabhi Agrawal & Associate for the year ended 31.03.2026
Outcome of Board Meeting25 May 2026
Board Meeting Outcome for Meeting Of Board Of Directors Held On 25.05.2026
1. Considered and approved Audited Financial Results for the Quarter and Financial Year ended 31st March, 2026 along with the along with the Auditors Report thereon, Statement of Assets ....
General19 May 2026
Clarification On Email Dated 19Th May, 2026 By BSE
The clarification has been attached herewith in pursuant to additional details required for the corporate announcement filed under Regulation 30
Change in Management18 May 2026
Announcement under Regulation 30 (LODR)-Change in Management
Intimation for appointment of Mrs. Stela Choksi as Chief Financial Officer of the company
Resignation of Chief Financial Officer (CFO)18 May 2026
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Intimation for resignation of Mr. Vyangesh Choksi as Chief Financial Officer of the company
Outcome of Board Meeting18 May 2026
Board Meeting Outcome for Outcome For Meeting Of Board Of Directors Held On 18Th May, 2026
1. Considered and reviewed for purchasing of 1 MG Windsor car in the name of company along with loan facilities from HDFC bank. 2. Discussed and approved for initiating the process of ....
Board Meeting16 May 2026
Board Meeting Intimation for Meeting Of Board Of Directors To Be Held On 25.05.2026
Choksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve 1.To consider and approve ....
Board Meeting13 May 2026
Board Meeting Intimation for Meeting Of Board Of Director To Be Held On 18Th May, 2026
Choksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 ,inter alia, to consider and approve 1.To consider and approve ....
Postal Ballot28 Apr 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Submission of scrutinizer report along with voting result of e-voting done by shareholder by means of postal ballot

Frequently Asked Questions

Where can I download the annual report of Choksi Laboratories Ltd.?

Annual reports of Choksi Laboratories Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Choksi Laboratories Ltd.?

Quarterly earnings results and presentations of Choksi Laboratories Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Choksi Laboratories Ltd. publish earnings call transcripts?

Earnings call transcripts of Choksi Laboratories Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Choksi Laboratories Ltd.?

Investor presentations and annual day presentations of Choksi Laboratories Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Choksi Laboratories Ltd.?

Corporate announcements and regulatory filings of Choksi Laboratories Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Choksi Laboratories Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Choksi Laboratories Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Choksi Laboratories Ltd.?

The ISIN (International Securities Identification Number) of Choksi Laboratories Ltd. is INE493D01013. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Choksi Laboratories Ltd. listed?

Choksi Laboratories Ltd. is listed on NSE and BSE. The NSE symbol is CHOKSILA and the BSE code is -.

Where can I find the shareholding pattern of Choksi Laboratories Ltd.?

The quarterly shareholding pattern of Choksi Laboratories Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Choksi Laboratories Ltd. on Sharpely?

Share price data for Choksi Laboratories Ltd. is updated as of 21 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.